{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-091002","form_type":"8-K","ticker":"TTRX","cik":"0002023016","company_name":"Turn Therapeutics Inc.","filed_at":"2026-08-18T12:30:15+00:00","discovered_at":"2026-08-18T12:35:00.266634+00:00","generated_at":"2026-08-18T12:35:18.577514+00:00","sec_items":["3.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Turn Therapeutics issues 579,664 shares to GEM on cashless warrant exercise","bullets":["On Aug 13, 2026, GEM exercised warrant in full via cashless provision; company issued 579,664 common shares.","Warrant originally covered 1,192,207 shares (4% fully diluted) at $5.03 exercise price, dated Oct 8, 2025.","Shares issued under Section 4(a)(2) exemption; GEM represented as accredited investor.","Exercise triggered because per-share market value exceeded $5.03 warrant price.","No new capital raised; dilution of ~0.5% of fully diluted shares (579,664 vs. prior total)."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-091002","json":"https://secwatch.observer/filing/0001213900-26-091002.json","markdown":"https://secwatch.observer/filing/0001213900-26-091002.md","text":"https://secwatch.observer/filing/0001213900-26-091002.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2023016/000121390026091002/0001213900-26-091002-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2023016/000121390026091002/ea0302512-8k_turn.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-18T12:35:18.577514+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}